Point72 Asset Management, L.P. 13D/13G Filings for Olema Pharmaceuticals, Inc. (OLMA)

Point72 Asset Management, L.P. 13D and 13G filings for Olema Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-06-14
4:34 pm
Purchase
2024-06-0413GOlema Pharmaceuticals, Inc.
OLMA
Point72 Asset Management, L.P.3,225,250
5.700%
3,225,250increase
(New Position)
Filing